A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize those ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Given the complexity of controlled substance regulations, organizations must take a proactive approach to compliance and ...

As sure as the sun rises, prescription medicine use and total drug spending continue to increase in the U.S. | Last year's ...

The U.S. Food and Drug Administration is warning Americans about the ever-increasing and potentially deadly recreational use ...

A “tidal wave” of a recently criminalised substance used to drug and sexually assault unsuspecting victims has reached ...

House Bill 1644, by state Rep. Tom Oliverson, R-Cypress, would remove testing strips for fentanyl and xylazine, a veterinary ...

Opposing interests in the health care world are escalating their fight over an Illinois bill targeting the 340B drug discount ...

The most expensive drug category for nonfederal hospitals in 2024 were antineoplastic targeted agents, according to a study published in the American Journal of Health-System Pharmacy.  The report, ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...